Taurine improves the wound healing process in cutaneous leishmaniasis in mice model, based on stereological parameters

Background: Cutaneous Leishmaniasis is a self-limiting disease caused by protozoan parasites of the genus Leishmania, which affects the skin with full-thickness wounds, which are prone to scar formation even after treatment. Taurine (Tu) is one of the most abundant amino acids that has antioxidant and anti-inflammatory effects, which play an important role in the process of wound healing. Herein, we have investigated the effects of Tu on cutaneous Leishmaniasis wounds and L. major promastigotes. Materials and Methods: Eighteen mice were induced with Leishmaniasis wounds (with L. Major) on the base of their tails and divided into three groups, T1: Treated with Tu injection, T2: Treated with Tu gel, and C: No treatment. Treatments were carried out every 24 hours for 21 days. The volume densities of the collagen bundles and vessels, vessel′s length density and diameter, and fibroblast populations were estimated by stereological methods. Flow cytometry was used in order to investigate the direct Tu effect on parasites. The Mann-Whitney U test was used and P ≤ 0.05 was considered to be statistically significant. Results: The numerical density of the fibroblasts, volume density of the collagen bundles, and length densities of the vessels in groups T1 and T2 were significantly higher than in group C (P < 0.05). The fibroblast numerical density of group T1 was higher than that of group T2 (P = 0.02). Incidentally, Tu had no direct effect on L. major parasites according to the flow cytometry analysis. Conclusion: Tu showed the ability to improve the wound healing process and tissue regeneration although it had no direct anti-leishmaniasis effect.

[1]  A. Noorafshan,et al.  Silymarin enhanced fibroblast proliferation and tissue regeneration in full thickness skin wounds in rat models; a stereological study , 2013 .

[2]  A. Noorafshan,et al.  The Healing Effect of Arnebia Euchroma in Second Degree Burn Wounds in Rat as an Animal Model , 2012, Iranian Red Crescent medical journal.

[3]  M. Koch,et al.  Effect of the topical use of the antioxidant taurine on the two basement membrane proteins of regenerating oral gingival epithelium. , 2012, Journal of periodontology.

[4]  M. Nilforoushzadeh,et al.  THE COMPARISON BETWEEN TRICHLOROACETIC ACID 50% AND CO2 LASER IN THE TREATMENT OF CUTANEOUS LEISHMANIASIS SCAR , 2011, Indian journal of dermatology.

[5]  H. Nahrevanian,et al.  An overview of a diagnostic and epidemiologic reappraisal of cutaneous leishmaniasis in Iran. , 2011, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[6]  M. Kalantari,et al.  Comparison of Three Methods for Diagnosis of Cutaneous Leishmaniasis , 2010, Iranian journal of parasitology.

[7]  A. Fernandes,et al.  Reductions in Skin and Systemic Parasite Burdens as a Combined Effect of Topical Paromomycin and Oral Miltefosine Treatment of Mice Experimentally Infected with Leishmania (Leishmania) amazonensis , 2010, Antimicrobial Agents and Chemotherapy.

[8]  H. Goto,et al.  Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis , 2010, Expert review of anti-infective therapy.

[9]  M. Nilforoushzadeh,et al.  Treatment of atrophic cutaneous leishmaniasis scar using autologous fibroblasts and keratinocytes (a case report and literature review) , 2010, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[10]  Decheng Lv,et al.  Copper-taurine (CT): a potential organic compound to facilitate infected wound healing. , 2009, Medical hypotheses.

[11]  R. Jachowicz,et al.  Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study. , 2008, European journal of dermatology : EJD.

[12]  E. von Stebut Cutaneous Leishmania infection: progress in pathogenesis research and experimental therapy , 2007, Experimental dermatology.

[13]  M. Mohebali,et al.  EMERGENCE OF CUTANEOUS LEISHMANIASIS DUE TO LEISHMANIA MAJOR IN A NEW FOCUS OF SOUTHERN IRAN , 2007 .

[14]  T. Speed,et al.  The wound repair response controls outcome to cutaneous leishmaniasis , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. Çelik,et al.  Increased DNA damage and oxidative stress in patients with cutaneous leishmaniasis. , 2005, Mutation research.

[16]  K. Makhoul,et al.  Cutaneous leishmaniasis: recognition and treatment. , 2004, American family physician.

[17]  S. Dinçer,et al.  Effect of taurine on wound healing , 1996, Amino Acids.

[18]  Rudy F. M. Lai A Fat,et al.  Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam , 2002, International journal of dermatology.

[19]  G. Take,et al.  An investigation on skin wound healing in mice with a taurine-chitosan gel formulation , 2002, Amino Acids.

[20]  J. Soto,et al.  Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  H. Zakai,et al.  Effects of itraconazole and terbinafine on Leishmania major lesions in BALB/c mice. , 2000, Annals of tropical medicine and parasitology.